美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apimeds Pharmaceutical U.S, Inc.

5.20

+0.18003.59%

盘后：5.11-0.0893-1.72%17:42 EDT

成交量：139.37万

成交额：779.78万

市值：784.74万

市盈率：-0.13

高：6.04

开：5.43

低：4.97

收：5.02

52周最高：59.70

52周最低：1.51

股本：150.91万

流通股本：72.59万

量比：0.07

换手率：191.98%

股息：- -

股息率：- -

每股收益(TTM):-38.5450

每股收益(LYR):-0.1759

净资产收益率：-144.99%

总资产收益率：-69.29%

市净率：0.96

市盈率(LYR):-29.57

数据加载中...

总览公司新闻资讯公告

Mindwave Innovations与美企Blockassure达成协议，将共同构建并运营端到端保险与再保险网络Assurechain

Apimeds Pharmaceutical U.S, Inc. 任命 Eric Sherb 为首席财务官，2026年10月1日起生效——SEC 文件

Mindwave Innovations加速美国商业布局，再签协议为纽约Flash Sports & Media建设并运营Flashchain

Mindwave Innovations：协议项下对价总金额尚未公开披露

Mindwave Innovations签署协议，将搭建并运营Aquaechain——面向受保Alci信用额度的平台

Apimeds Pharmaceuticals US董事会过渡期调整：仅保留四名成员——SEC文件披露

Apimeds Pharmaceuticals US于2026年9月10日签署和解协议第一修正案——SEC文件披露

SEC文件揭示：Freet已将全部Apitox相关权利转让予Apimeds Pharmaceuticals

Apimeds Pharmaceuticals US获Apitox韩国诊所独家权利、美国25%特许权使用费及海外25%收入分成——SEC文件披露

Apimeds制药美国公司依据和解协议，将在七个工作日内设立全新全资子公司

Apimeds Pharmaceuticals US与Inscobee达成和解；合并进程继续，1亿美元PIPE融资即将完成，LŌKahi Therapeutics将推进Apitox项目

Apimeds Pharmaceuticals US Inc任命蔡成俊为联席首席执行官 2026年5月4日生效 - 美国证券交易委员会备案文件

Apimeds制药美国公司 - Lokahi保留Apitox项目全部权利含220万美元Prevail CRO信贷额度 - 美国证监会文件

Apimeds制药美国公司与Inscobee达成和解协议

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/APUS/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical  U.S, Inc.","latestPrice":5.2,"timestamp":1791835200000,"preClose":5.02,"halted":0,"volume":1393676,"hourTrading":{"tag":"盘后","latestPrice":5.1107,"preClose":5.2,"latestTime":"17:42 EDT","volume":13924,"amount":70866.323316,"timestamp":1791841340101,"change":-0.0893,"changeRate":-0.017173,"amplitude":0.042308},"delay":0,"changeRate":0.035856573705179404,"floatShares":725942,"shares":1509119,"eps":-38.545,"marketStatus":"盘后交易","change":0.18,"latestTime":"10-12 17:44:46 EDT","open":5.43,"high":6.0356,"low":4.9706,"amount":7797824.320253599,"amplitude":0.212151,"askPrice":5.2,"askSize":7,"bidPrice":5.01,"bidSize":118,"shortable":0,"etf":0,"ttmEps":-38.545,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791849600000},"marketStatusCode":4,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":5.02,"preHourTrading":{"tag":"盘前","latestPrice":5.5,"preClose":5.02,"latestTime":"09:29 EDT","volume":231853,"amount":1339588.67075,"timestamp":1791811757039,"change":0.48,"changeRate":0.095618,"amplitude":0.326096},"postHourTrading":{"tag":"盘后","latestPrice":5.1107,"preClose":5.2,"latestTime":"17:42 EDT","volume":13924,"amount":70866.323316,"timestamp":1791841340101,"change":-0.0893,"changeRate":-0.017173,"amplitude":0.042308},"volumeRatio":0.066695},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","floatShares":725942,"roa":"-69.29%","roe":"-144.99%","lyrEps":-0.175862,"volumeRatio":0.066695,"shares":1509119,"dividePrice":0,"high":6.0356,"amplitude":0.212151,"preClose":5.02,"low":4.9706,"week52Low":1.51,"pbRate":"0.96","week52High":59.7,"institutionHeld":0,"latestPrice":5.2,"committee":0.888,"eps":-38.545,"divideRate":0,"volume":1393676,"delay":0,"ttmEps":-38.545,"open":5.43,"prevYearClose":16.4,"prevWeekClose":5.02,"prevMonthClose":5,"prevQuarterClose":5,"fiveDayClose":4.59,"twentyDayClose":2.09,"sixtyDayClose":6.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-24","symbol":"APUS","defaultRemindTime":1784899800000,"type":"split","dateTimestamp":1784865600000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APUS","date":"2025-12-01","current":-0.134907,"percent":0.642384,"low":-37.866629,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"high":-4.754876,"avg":-11.953693,"sd":7.073766,"marketCap":36470350},"quantilePoints":[{"date":"2025-02-21","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-02-28","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-03-05","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-05-09","current":-18.309826,"twenty":-34.716764,"median":-34.716764,"eighty":-33.299512,"marketCap":25450475},{"date":"2025-05-16","current":-14.148502,"twenty":-34.716764,"median":-34.008138,"eighty":-15.063993,"marketCap":19666276},{"date":"2025-05-23","current":-14.074662,"twenty":-34.716764,"median":-18.309826,"eighty":-14.306662,"marketCap":21054484},{"date":"2025-05-30","current":-13.387434,"twenty":-34.716764,"median":-15.063993,"eighty":-14.061031,"marketCap":20026450},{"date":"2025-06-06","current":-14.702962,"twenty":-34.716764,"median":-14.800251,"eighty":-13.996937,"marketCap":21994367},{"date":"2025-06-13","current":-14.314495,"twenty":-34.716764,"median":-14.564634,"eighty":-14.061031,"marketCap":21413253},{"date":"2025-06-20","current":-13.774354,"twenty":-33.866413,"median":-14.548195,"eighty":-14.0474,"marketCap":20605249},{"date":"2025-06-27","current":-13.296895,"twenty":-33.299512,"median":-14.356338,"eighty":-13.867215,"marketCap":19891011},{"date":"2025-07-03","current":-13.774354,"twenty":-27.303638,"median":-14.27266,"eighty":-13.727614,"marketCap":20605249},{"date":"2025-07-11","current":-14.006506,"twenty":-17.177946,"median":-14.161274,"eighty":-13.727614,"marketCap":20952529},{"date":"2025-07-18","current":-13.851738,"twenty":-15.354982,"median":-14.154888,"eighty":-13.727614,"marketCap":20721009},{"date":"2025-07-25","current":-16.173259,"twenty":-16.219689,"median":-14.161274,"eighty":-13.727614,"marketCap":24193804},{"date":"2025-08-01","current":-13.464818,"twenty":-16.219689,"median":-14.199966,"eighty":-13.727614,"marketCap":20142210},{"date":"2025-08-08","current":-12.14929,"twenty":-16.049445,"median":-14.148502,"eighty":-13.573156,"marketCap":18174293},{"date":"2025-08-15","current":-12.265366,"twenty":-15.710284,"median":-14.056061,"eighty":-13.418388,"marketCap":18347933},{"date":"2025-08-22","current":-7.697345,"twenty":-15.447843,"median":-14.006506,"eighty":-13.015991,"marketCap":28547481},{"date":"2025-08-29","current":-6.307075,"twenty":-15.306558,"median":-13.929122,"eighty":-12.721932,"marketCap":23391328},{"date":"2025-09-05","current":-6.307075,"twenty":-15.146611,"median":-13.929122,"eighty":-12.474303,"marketCap":23391328},{"date":"2025-09-12","current":-6.578348,"twenty":-15.038217,"median":-13.851738,"eighty":-12.234412,"marketCap":24397407},{"date":"2025-09-19","current":-6.205348,"twenty":-14.9276,"median":-13.774354,"eighty":-7.507455,"marketCap":23014048},{"date":"2025-09-26","current":-6.049367,"twenty":-14.889578,"median":-13.773581,"eighty":-6.849619,"marketCap":22435553},{"date":"2025-10-03","current":-5.832349,"twenty":-14.826776,"median":-13.69697,"eighty":-6.578348,"marketCap":21630690},{"date":"2025-10-10","current":-6.307075,"twenty":-14.675296,"median":-13.542202,"eighty":-6.472551,"marketCap":23391328},{"date":"2025-10-17","current":-6.239257,"twenty":-14.561346,"median":-13.50351,"eighty":-6.415584,"marketCap":23139808},{"date":"2025-10-24","current":-5.879822,"twenty":-14.548195,"median":-13.387434,"eighty":-6.358617,"marketCap":21806754},{"date":"2025-10-31","current":-6.917438,"twenty":-14.538909,"median":-13.039206,"eighty":-6.374893,"marketCap":25655005},{"date":"2025-11-07","current":-8.524725,"twenty":-14.481047,"median":-12.845746,"eighty":-6.381675,"marketCap":31616021},{"date":"2025-11-14","current":-9.460613,"twenty":-14.381444,"median":-12.652286,"eighty":-6.415584,"marketCap":35086992},{"date":"2025-11-21","current":-5.852155,"twenty":-14.312928,"median":-12.458826,"eighty":-6.415584,"marketCap":30182359},{"date":"2025-11-28","current":-7.071353,"twenty":-14.306662,"median":-12.304058,"eighty":-6.374893,"marketCap":36470350},{"date":"2025-12-01","current":-7.071353,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"marketCap":36470350}],"updateTime":1791841486577},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APUS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1160417679","title":"Mindwave Innovations与美企Blockassure达成协议，将共同构建并运营端到端保险与再保险网络Assurechain","url":"https://stock-news.laohu8.com/highlight/detail?id=1160417679","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160417679?lang=zh_cn&edition=fundamental","pubTime":"2026-10-05 20:02","pubTimestamp":1791201741,"startTime":"0","endTime":"0","summary":"Mindwave Innovations与总部位于美国的Blockassure签署协议，双方将联手打造并运营Assurechain——一个覆盖保险与再保险全链条的端到端网络。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134100205","title":"Apimeds Pharmaceutical U.S, Inc. 任命 Eric Sherb 为首席财务官，2026年10月1日起生效——SEC 文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1134100205","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134100205?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 21:17","pubTimestamp":1790860629,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceutical U.S, Inc. 宣布，Eric Sherb 将出任公司首席财务官一职，该任命自2026年10月1日起正式生效。此消息来自一份提交给美国证券交易委员会（SEC）的文件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111090746","title":"Mindwave Innovations加速美国商业布局，再签协议为纽约Flash Sports & Media建设并运营Flashchain","url":"https://stock-news.laohu8.com/highlight/detail?id=1111090746","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111090746?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 20:34","pubTimestamp":1790685253,"startTime":"0","endTime":"0","summary":"Mindwave Innovations加速美国商业布局，再签协议为纽约Flash Sports & Media建设并运营Flashchain","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167828280","title":"Mindwave Innovations：协议项下对价总金额尚未公开披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1167828280","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167828280?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 20:34","pubTimestamp":1790685252,"startTime":"0","endTime":"0","summary":"Mindwave Innovations：各方均未公开披露协议项下对价的总美元价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171041162","title":"Mindwave Innovations签署协议，将搭建并运营Aquaechain——面向受保Alci信用额度的平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1171041162","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171041162?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 20:31","pubTimestamp":1790253107,"startTime":"0","endTime":"0","summary":"Mindwave Innovations已达成一项协议，将负责搭建并运营Aquaechain。该平台专为受保Alci信用额度而设计。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121862226","title":"Apimeds Pharmaceuticals US董事会过渡期调整：仅保留四名成员——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1121862226","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121862226?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 21:13","pubTimestamp":1789132390,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新提交的文件，Apimeds Pharmaceuticals US公司透露，在过渡期内其董事会成员将缩减至仅四名。市场观察人士或将对此举动的潜在意图及其对公司决策流程的影响保持关注。外界普遍推测，此举或在为更广泛的治理改革铺路，不过截至目前，官方未就成员缩减的具体原因或预计过渡期时长给出明确说明。随着更多细节浮出水面，投资者与行业分析者预计将密切关注这一发展动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157325852","title":"Apimeds Pharmaceuticals US于2026年9月10日签署和解协议第一修正案——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1157325852","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157325852?lang=zh_cn&edition=fundamental","pubTime":"2026-09-11 21:12","pubTimestamp":1789132331,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US——这家制药公司于2026年9月10日签署了和解协议的第一修正案。相关细节已通过美国证券交易委员会（SEC）的文件正式对外披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142452397","title":"SEC文件揭示：Freet已将全部Apitox相关权利转让予Apimeds Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1142452397","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142452397?lang=zh_cn&edition=fundamental","pubTime":"2026-08-22 05:14","pubTimestamp":1787346850,"startTime":"0","endTime":"0","summary":"一项最新提交至美国证券交易委员会的文件显示，Apimeds Pharmaceuticals US已获得Freet方面转让的全部Apitox相关权益。这一动作意味着，围绕Apitox的所有权归属问题，如今已有了明确的界定与交接。根据该文件内容，Freet将其与Apitox相关的所有权利完整地转移给了Apimeds Pharmaceuticals。此举或将对Apimeds Pharmaceuticals未来的业务布局与产品管线产生深远影响。随着权利的正式移交，Apimeds Pharmaceuticals US如今握有更为集中的资源，未来其如何利用这一优势，值得持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111642266","title":"Apimeds Pharmaceuticals US获Apitox韩国诊所独家权利、美国25%特许权使用费及海外25%收入分成——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1111642266","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111642266?lang=zh_cn&edition=fundamental","pubTime":"2026-08-22 05:14","pubTimestamp":1787346850,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新披露的文件，Apimeds Pharmaceuticals US已就其核心产品Apitox达成一项重要协议。该公司获得了该产品在韩国诊所领域的100%独家权利，同时在美国市场享有25%的特许权使用费，并可参与海外市场25%的收入分成。协议条款清晰界定了各区域市场的利益分配机制——韩国市场侧重权利掌控，美国及海外市场则通过收益共享模式实现多方共赢。文件内容显示，此次权利与收益分配方案已正式确立，为Apitox的全球市场推广奠定了明确的商业框架。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170470171","title":"Apimeds制药美国公司依据和解协议，将在七个工作日内设立全新全资子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1170470171","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170470171?lang=zh_cn&edition=fundamental","pubTime":"2026-05-06 02:09","pubTimestamp":1778004553,"startTime":"0","endTime":"0","summary":"根据最新达成的和解协议条款，Apimeds制药美国公司已承诺在七个工作日的期限内完成全新全资子公司的组建工作。这一举措标志着公司在战略重组方面迈出关键一步，旨在优化业务架构并提升运营效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111825147","title":"Apimeds Pharmaceuticals US与Inscobee达成和解；合并进程继续，1亿美元PIPE融资即将完成，LŌKahi Therapeutics将推进Apitox项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1111825147","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111825147?lang=zh_cn&edition=fundamental","pubTime":"2026-05-06 02:07","pubTimestamp":1778004434,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceutical U.S, Inc.已与Inscobee达成和解协议，公司合并计划将按原定方案继续推进。与此同时，一项高达1亿美元的PIPE融资也即将完成交割。\n作为合并后实体的一部分，LŌKahi Therapeutics将获得资金支持，重点推进其Apitox项目的研发进程。这一系列进展标志着公司在战略布局和资本运作方面取得重要突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163822956","title":"Apimeds Pharmaceuticals US Inc任命蔡成俊为联席首席执行官 2026年5月4日生效 - 美国证券交易委员会备案文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1163822956","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163822956?lang=zh_cn&edition=fundamental","pubTime":"2026-05-06 00:32","pubTimestamp":1777998734,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新备案文件披露，Apimeds Pharmaceuticals US Inc（股票代码：APUS）已正式任命蔡成俊（Sungjoon Chae）担任公司联席首席执行官。此项高管人事变动将于2026年5月4日正式生效。\n此次任命标志着该公司在战略领导层配置上的重要调整。蔡成俊将与其他高管团队协同工作，共同推动公司的业务发展和战略规划实施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190941409","title":"Apimeds制药美国公司 - Lokahi保留Apitox项目全部权利 含220万美元Prevail CRO信贷额度 - 美国证监会文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1190941409","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190941409?lang=zh_cn&edition=fundamental","pubTime":"2026-05-04 18:20","pubTimestamp":1777890015,"startTime":"0","endTime":"0","summary":"根据美国证监会最新披露文件，Apimeds制药美国公司（APUS）宣布其合作伙伴Lokahi已全面保留对Apitox项目的所有权利。此项权利保留协议涵盖价值220万美元的Prevail合同研究组织信贷额度，标志着该项目资产关系的正式确认。\n该安排确保了Lokahi对Apitox研发计划的完整控制权，同时维持了与Prevail CRO的金融合作框架。此次权利确认将为Apitox项目的后续临床开发提供稳定的资金支持与法律保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158149099","title":"Apimeds制药美国公司与Inscobee达成和解协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1158149099","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158149099?lang=zh_cn&edition=fundamental","pubTime":"2026-05-04 18:19","pubTimestamp":1777889954,"startTime":"0","endTime":"0","summary":"根据2026年4月24日提交给美国证券交易委员会的文件显示，Apimeds制药美国公司已与Inscobee正式签署和解协议。该协议的达成标志着双方长期争议的终结，为企业未来的稳定发展奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}